New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer
Publication in refereed journal

Times Cited
Altmetrics Information

Other information
AbstractThe gastrointestinal tract represents one of the largest interfaces between the host and environmental factors. It contains a vast and complex community of microbes, forming what is collectively known as the microbiota. This gut microbiota plays a pivotal role in the maintenance of health, and 'dysbiosis' of the gut microbiota, commonly considered as perturbation of microbiota diversity and composition, has been associated with intestinal and extra-intestinal diseases, including non-alcoholic fatty liver disease (NAFLD) and its associated hepatocellular carcinoma (NAFLD-HCC).

In this review, we highlight microbiota dysbiosis and the microbiota-host interactions that link to the pathogenesis of NAFLD and NAFLD-HCC. We discuss the potential therapeutic implications of the gut microbiota in the progression of NAFLD-HCC.
All Author(s) ListNiama Ezzaidi, Xiang Zhang, Olabisi Oluwabukola Coker, Jun Yu
Journal nameCancer Letters
Volume Number459
Pages186 - 191
LanguagesEnglish-United States

Last updated on 2020-06-07 at 02:12